Sanofi (SNYNF)
78.49
+0.51
(+0.66%)
USD |
OTCM |
Oct 05, 16:00
Sanofi Price to Book Value : 1.322 for Oct. 5, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 05, 2026 | 1.322 |
| October 02, 2026 | 1.313 |
| October 01, 2026 | 1.353 |
| September 30, 2026 | 1.360 |
| September 29, 2026 | 1.350 |
| September 28, 2026 | 1.363 |
| September 25, 2026 | 1.347 |
| September 24, 2026 | 1.376 |
| September 23, 2026 | 1.363 |
| September 22, 2026 | 1.395 |
| September 21, 2026 | 1.438 |
| September 18, 2026 | 1.413 |
| September 17, 2026 | 1.440 |
| September 16, 2026 | 1.440 |
| September 15, 2026 | 1.440 |
| September 14, 2026 | 1.440 |
| September 11, 2026 | 1.415 |
| September 10, 2026 | 1.471 |
| September 09, 2026 | 1.432 |
| September 08, 2026 | 1.467 |
| September 04, 2026 | 1.504 |
| September 03, 2026 | 1.504 |
| September 02, 2026 | 1.488 |
| September 01, 2026 | 1.518 |
| August 31, 2026 | 1.520 |
| Date | Value |
|---|---|
| August 28, 2026 | 1.534 |
| August 27, 2026 | 1.510 |
| August 26, 2026 | 1.510 |
| August 25, 2026 | 1.559 |
| August 24, 2026 | 1.559 |
| August 21, 2026 | 1.574 |
| August 20, 2026 | 1.525 |
| August 19, 2026 | 1.525 |
| August 18, 2026 | 1.516 |
| August 17, 2026 | 1.464 |
| August 14, 2026 | 1.484 |
| August 13, 2026 | 1.467 |
| August 12, 2026 | 1.467 |
| August 11, 2026 | 1.466 |
| August 10, 2026 | 1.446 |
| August 07, 2026 | 1.489 |
| August 06, 2026 | 1.470 |
| August 05, 2026 | 1.400 |
| August 04, 2026 | 1.400 |
| August 03, 2026 | 1.412 |
| July 31, 2026 | 1.413 |
| July 30, 2026 | 1.396 |
| July 29, 2026 | 1.530 |
| July 28, 2026 | 1.502 |
| July 27, 2026 | 1.491 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| AstraZeneca PLC | 10.39 |
| GSK Plc | 4.024 |
| Novartis AG | 6.202 |
| Pfizer Inc. | 1.838 |
| Roche Holding AG | -- |
Price to Book Value Related Metrics
| PE Ratio | 20.21 |
| PS Ratio | 1.774 |
| PEG Ratio | 2.869 |
| Price to Free Cash Flow | 9.591 |
| Price | 78.49 |
| Earnings Yield | 4.95% |
| Market Cap | 95.29B |
| PEGY Ratio | 1.529 |
| Operating PE Ratio | 6.527 |
| Normalized PE Ratio | 11.42 |